Chidamide Combines With VP-16 and Methylprednisolone in the Treatment of HLH

  • End date
    Jul 1, 2023
  • participants needed
  • sponsor
    Beijing Friendship Hospital
Updated on 5 December 2021


Chidamide combines with VP-16 and methylprednisolone in HLH


This study aimed to investigate the efficacy and safety of Chidamide together with Etoposide and methylprednisolone for hemophagocytic lymphohistiocytosis

Condition Chidamide, Hemophagocytic lymphohistiocytosis
Treatment Chidamide combines with VP-16 and methylprednisolone
Clinical Study IdentifierNCT05137522
SponsorBeijing Friendship Hospital
Last Modified on5 December 2021


Yes No Not Sure

Inclusion Criteria

Meet hemophagocytic lymphohistiocytosis (HLH)-04 diagnostic
criteria; patients were diagnosed with EBV associated HLH (EBV-HLH) and
lymphoma associated HLH.Age 18 years old, gender is not limited. Serum
creatinine 1.5 times normalNT-proBNP normalInformed consent obtained

Exclusion Criteria

Active bleeding of the internal organs or patients with
new thrombotic diseasesAllergic to Chidamide and etoposideParticipate in other
clinical research at the same timeHIV , HBV and HCV infected patients (HIV
antibody positive)History of QT interval prolongation, atrioventricular block
ventricular tachycardia, coronary atherosclerotic heart diseasePregnant or
lactating women and patients of childbearing age who refuse to take
appropriate contraceptive measures during this trial. If the patient was male
he refused to use adequate contraceptive methods or donate semen during the
study period and within 3 months after receiving the last cycle of drug
studypatients judged by the investigator to be unsuitable to participate in
this study
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note